Immunoblotting analysis showed that after 48 h of treatment with PTE, the expression levels of MMP-2 and MMP-9 proteins in glioma cells were significantly reduced and dose-dependent (Fig. 4E). Here, MMP9 is linked to central nervous system cancer.